Document Detail


Survival among patients with HIV infection and smear-negative pulmonary tuberculosis - United States, 1993-2006.
MedLine Citation:
PMID:  23110113     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: In patients with HIV and tuberculosis (TB) in resource-constrained settings, smear-negative disease has been associated with higher mortality than smear-positive disease. Higher reported mortality may be due to misdiagnosis, diagnostic delays, or because smear-negative disease indicates more advanced immune suppression.
METHODS: We analyzed culture-confirmed, pulmonary TB among patients with TB and HIV in the United States from 1993-2008 to calculate prevalence ratios (PRs) for smear-negative disease by demographic and clinical characteristics. Allowing two years for treatment outcome to be reported, we determined hazard ratios (HRs) for survival by smear status, adjusted for significant covariates on patients before 2006.
RESULTS: Among 16,710 cases with sputum smear results, 6,739 (39%) were sputum smear-negative and 9,971 (58%) were sputum smear-positive. The prevalence of smear-negative disease was lower in male patients (PR: 0.89, 95% confidence interval [CI]: 0.86-0.93) and in those who were homeless (PR: 0.92, CI: 0.87-0.97) or used alcohol excessively (PR: 0.91, CI: 0.87-0.95), and higher in persons diagnosed while incarcerated (PR: 1.20, CI: 1.13-1.27). Patients with smear-negative disease had better survival compared to patients with smear-positive disease, both before (HR: 0.82, CI: 0.75-0.90) and after (HR: 0.81, CI: 0.71-0.92) the introduction of combination anti-retroviral therapy.
CONCLUSIONS: In the United States, smear-negative pulmonary TB in patients with HIV was not associated with higher mortality, in contrast to what has been documented in high TB burden settings. Smear-negative TB can be routinely and definitively diagnosed in the United States, whereas high-burden countries often rely solely on AFB-smear microscopy. This difference could contribute to diagnostic and treatment delays in high-burden countries, possibly resulting in higher mortality.
Authors:
J Sean Cavanaugh; N Sarita Shah; Kevin P Cain; Carla A Winston
Related Documents :
23897193 - Two cases of glomerulonephritis in one patient infected with the hepatitis c virus.
23670173 - Pgp 9.5 neuronal marker may differentiate immunohistochemically hiv-related from medite...
17685983 - Hepatic encephalopathy in a pregnant mare: identification of histopathological changes ...
Publication Detail:
Type:  Historical Article; Journal Article; Research Support, U.S. Gov't, P.H.S.     Date:  2012-10-23
Journal Detail:
Title:  PloS one     Volume:  7     ISSN:  1932-6203     ISO Abbreviation:  PLoS ONE     Publication Date:  2012  
Date Detail:
Created Date:  2012-10-30     Completed Date:  2013-04-11     Revised Date:  2013-07-11    
Medline Journal Info:
Nlm Unique ID:  101285081     Medline TA:  PLoS One     Country:  United States    
Other Details:
Languages:  eng     Pagination:  e47855     Citation Subset:  IM    
Affiliation:
Epidemic Intelligence Service Officer, Division of Tuberculosis Elimination, U. S. Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America. hgi7@cdc.gov
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Female
HIV Infections / complications*,  mortality*
History, 20th Century
History, 21st Century
Humans
Male
Prevalence
Sex Factors
Sputum / microbiology
Survival Analysis
Tuberculosis, Pulmonary / complications*,  diagnosis,  mortality*
United States / epidemiology
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Immune modulation mediated by cryptococcal laccase promotes pulmonary growth and brain dissemination...
Next Document:  Adipokine hormones and hand osteoarthritis: radiographic severity and pain.